Narkhyun Bae
@ghostbnh
TPD Drug Discovery Group Leader at Daewoong Pharmaceutical Co.,Ltd./Biochemist&Chemical Biologist
ID: 180934452
https://www.linkedin.com/in/narkhyun-bae-06406221 20-08-2010 21:46:00
2,2K Tweet
509 Takipçi
1,1K Takip Edilen
Cancer cell therapies: global clinical trial trends and emerging directions nature.com/articles/d4157… This new article by authors Cancer Research Institute analyses trends across trial phases, indications, modalities, cell sources and targets to map the current trajectory of the field
In classical PDAC, tumour drivers change with the disease state: 🔹 Primary tumors rely on HNF4G 🔹 Metastasis emerges as FOXA1 becomes derepressed Our new research briefing in Nature Genetics breaks down this transcriptional shift and its implications- nature.com/articles/s4158…
Now online in Cancer Discovery: DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML, but Is Associated With Increased Leukemia Stem Cell Frequency - by Thomas Köhnke, Daiki Karigane Majeti Lab and colleagues doi.org/10.1158/2159-8… Stanford Medicine